FIM
AZN icon

FWL Investment Management’s AstraZeneca AZN Stock Holding History

FWL Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$872K Buy
4,601
+95
+2% +$17.9K 0.16% 65
2026
Q1 		$889K Buy
4,506
+4,423
+5,329% +$853K 0.2% 56
2025
Q4 		$15.2K Buy
+83
New +$14.6K ﹤0.01% 240
2025
Q3 		– Sell
-8
Closed -$1.12K – 336
2025
Q2 		$1.12K Buy
+8
New +$1.12K ﹤0.01% 315

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FWL Investment Management's AZN Position: Q2 2026 in Review

FWL Investment Management increased its AstraZeneca (AZN) stake by 2.1% in Q2 2026, buying an estimated $17.9K and bringing the position to 4,601 shares worth $872K. The position accounts for 0.16% of the portfolio, ranked #65.

FWL Investment Management first reported a position in AZN in Q2 2025 and has held it in 4 quarters since. The position peaked at $889K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • FWL Investment Management held 4,601 shares of AstraZeneca worth $872K as of Q2 2026.
  • FWL Investment Management bought 95 AstraZeneca shares in Q2 2026, an estimated $17.9K.
  • AstraZeneca made up 0.16% of FWL Investment Management's portfolio in Q2 2026, its #65 holding.
  • FWL Investment Management first reported a position in AstraZeneca in Q2 2025 and has held it in 4 quarters since.
  • FWL Investment Management's AstraZeneca position peaked at $889K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.